Semaglutide and tirzepatide are often grouped together because they belong to the broader family of incretin-based medications used for type 2 diabetes and, in some cases, weight management. But they are not the same molecule, and the differences matter when you are talking with a clinician about which one fits your situation.

How semaglutide and tirzepatide differ

Semaglutide, the active ingredient in medications like Ozempic and Wegovy, is a GLP-1 receptor agonist. It mimics one gut hormone, GLP-1, that helps regulate appetite, blood sugar, and the rate at which the stomach empties.

Tirzepatide, the active ingredient in Mounjaro and Zepbound, acts on two receptors. It mimics GLP-1 and another gut hormone called GIP. This dual action is part of why clinical trials have generally shown larger average weight loss with tirzepatide compared with semaglutide, though individual response varies widely.

What a provider weighs when choosing

In practice, the differences a provider may discuss with you include:

  • Average weight outcomes seen in clinical trials, with the caveat that averages are not predictions
  • Side effect profiles, which overlap heavily but can feel different person to person
  • Dosing schedules and titration plans
  • Cost and insurance coverage in your region
  • Availability and whether compounding is involved
  • Your medical history, including any history of pancreatitis, thyroid issues, or gastrointestinal conditions

GLP-1 medications and midlife women

For women in midlife specifically, the conversation often goes beyond which medication has the bigger trial number. Perimenopause and menopause shift insulin sensitivity, sleep, and how the body holds onto fat at the waist. A clinician who understands that context can help weigh whether either medication makes sense, and how it fits alongside sleep, strength training, protein intake, and any hormone therapy you are considering.

Which one is right for you?

It is also worth understanding that neither medication is meant to be a short-term fix taken in isolation. Both work best inside a broader plan that addresses how you eat, move, sleep, and recover. Stopping the medication without that foundation often means weight returns.

The right question is not which medication is best in general. It is which one, if any, fits your body, your history, and the plan you can actually sustain. That conversation belongs with a clinician who has the time to have it.